Cargando…

Structure-Based Discovery of N-Sulfonylpiperidine-3-Carboxamides as Novel Capsid Assembly Modulators for Potent Inhibition of HBV Replication

As a key element during HBV replication, a nucleocapsid is considered a promising target for the treatment of chronic hepatitis B. The present study aimed to identify small molecules as novel capsid assembly modulators with antiviral activity. Structure-based virtual screening of an integrated compo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Yan, Yu, Yin, Jiaxin, Hu, Jie, Cai, Xuefei, Hu, Jieli, Xia, Jie, Wang, Kai, Tang, Ni, Huang, Luyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876525/ https://www.ncbi.nlm.nih.gov/pubmed/35215939 http://dx.doi.org/10.3390/v14020348

Ejemplares similares

The Infection Efficiency and Replication Ability of Circularized HBV DNA Optimized the Linear HBV DNA in Vitro and in Vivo
por: Li, Xiaosong, et al.
Publicado: (2015)

O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner
por: Yang, Yang, et al.
Publicado: (2023)

Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly
por: Xiao, Yu, et al.
Publicado: (2019)

Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus
por: Hwang, Nicky, et al.
Publicado: (2021)

Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication
por: Barral, Karine, et al.
Publicado: (2011)

Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives
por: Taverniti, Valerio, et al.
Publicado: (2022)

Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors
por: Fang, Feifei, et al.
Publicado: (2023)

Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV Infection
por: Zhang, Hong, et al.
Publicado: (2020)

Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein
por: Zheng, Yuan, et al.
Publicado: (2023)

The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases
por: Zhang, Xiaonan, et al.
Publicado: (2022)

Targeting the HIV-1 and HBV Capsids, an EnCore
por: McFadden, William M., et al.
Publicado: (2023)

Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)
por: Senaweera, Sameera, et al.
Publicado: (2022)

Design, synthesis and evaluation of 3-phenoxypyrazine-2-carboxamide derivatives as potent TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2022)

Design and Synthesis of Hepatitis B Virus (HBV) Capsid Assembly Modulators and Evaluation of Their Activity in Mammalian Cell Model
por: Spunde, Karina, et al.
Publicado: (2022)

Pharmacomodulation of a ligand targeting the HBV capsid hydrophobic pocket
por: Briday, Mathilde, et al.
Publicado: (2022)

Replication/Assembly Defective Avian Flavivirus With Internal Deletions in the Capsid Can Be Used as an Approach for Living Attenuated Vaccine
por: He, Yu, et al.
Publicado: (2021)

Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
por: Baragaña, Beatriz, et al.
Publicado: (2016)

Advances in HBV infection and replication systems in vitro
por: Xu, Ruirui, et al.
Publicado: (2021)

Benzoxazolone Carboxamides: Potent and Systemically Active Inhibitors of Intracellular Acid Ceramidase**
por: Pizzirani, Daniela, et al.
Publicado: (2015)

MicroRNA-141 Represses HBV Replication by Targeting PPARA
por: Hu, Wei, et al.
Publicado: (2012)

HBV replication is significantly reduced by IL-6
por: Kuo, Tzer-Min, et al.
Publicado: (2009)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses
por: Makarov, Vadim A, et al.
Publicado: (2015)

Correction: MicroRNA-141 Represses HBV Replication by Targeting PPARA
por: Hu, Wei, et al.
Publicado: (2012)

Identification of STAU1 as a regulator of HBV replication by TurboID-based proximity labeling
por: Wei, Xia-Fei, et al.
Publicado: (2022)

Discovery of novel pyridine carboxamides with antifungal activity as potential succinate dehydrogenase inhibitors
por: Yan, Zhongzhong, et al.
Publicado: (2022)

Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus
por: Mousnier, Aurélie, et al.
Publicado: (2018)

Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication
por: Iwamoto, Masashi, et al.
Publicado: (2017)

A Unique Role of the Human Cytomegalovirus Small Capsid Protein in Capsid Assembly
por: Borst, Eva Maria, et al.
Publicado: (2022)

The SUMOylation of Human Cytomegalovirus Capsid Assembly Protein Precursor (UL80.5) Affects Its Interaction with Major Capsid Protein (UL86) and Viral Replication
por: Zhang, Zhigang, et al.
Publicado: (2023)

Bluetongue Virus Capsid Assembly and Maturation
por: Mohl, Bjorn-Patrick, et al.
Publicado: (2014)

The Dynamics of Viruslike Capsid Assembly and Disassembly
por: Timmermans, Suzanne B. P. E., et al.
Publicado: (2022)

The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion
por: Chou, Shu-Fan, et al.
Publicado: (2015)

Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication
por: Zhong, L, et al.
Publicado: (2015)

Discovery of Flavone Derivatives Containing Carboxamide Fragments as Novel Antiviral Agents
por: Zhao, Bobo, et al.
Publicado: (2023)

Pyrimidine-2-carboxamide
por: Zhang, Bing-Yu, et al.
Publicado: (2007)

Bacteriophage MS2 displays unreported capsid variability assembling T = 4 and mixed capsids
por: de Martín Garrido, Natàlia, et al.
Publicado: (2019)

CUL4B facilitates HBV replication by promoting HBx stabilization
por: Shan, Haixia, et al.
Publicado: (2022)

Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase
por: Qiu, Yan, et al.
Publicado: (2016)

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
por: Hu, Zili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lgdhmubrskbsnag405lnonodas